Tenaya Therapeutics Stock Analysis

Tenaya Stock Analysis Notes

About 74.0% of the company shares are owned by institutional investors. The book value of Tenaya Therapeutics was at this time reported as 1.42. The company recorded a loss per share of 1.44. Tenaya Therapeutics had not issued any dividends in recent years. Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company was incorporated in 2016 and is headquartered in South San Francisco, California. Tenaya Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 135 people. To find out more about Tenaya Therapeutics contact Faraz MBA at 650 825 6990 or learn more at https://www.tenayatherapeutics.com.

Tenaya Therapeutics Investment Alerts

Tenaya Therapeutics Upcoming and Recent Events

Tenaya Largest EPS Surprises

View All Earnings Estimates

Tenaya Therapeutics Environmental, Social, and Governance (ESG) Scores

Tenaya Stock Institutional Investors

Note, although Tenaya Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tenaya Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 282.82 M.

Tenaya Profitablity

Management Efficiency

Tenaya Therapeutics has return on total asset (ROA) of (0.4594) % which means that it has lost $0.4594 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8449) %, meaning that it created substantial loss on money invested by shareholders. Tenaya Therapeutics' management efficiency ratios could be used to measure how well Tenaya Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of December 2, 2024, Return On Tangible Assets is expected to decline to -0.76. In addition to that, Return On Capital Employed is expected to decline to -0.93. At present, Tenaya Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 293.9 M, whereas Non Current Assets Total are forecasted to decline to about 50.9 M.

Technical Drivers

As of the 2nd of December, Tenaya Therapeutics has the Risk Adjusted Performance of 0.0816, coefficient of variation of 1053.23, and Semi Deviation of 4.68. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tenaya Therapeutics, as well as the relationship between them.

Tenaya Therapeutics Price Movement Analysis

Tenaya Therapeutics Insider Trading Activities

Tenaya Therapeutics Outstanding Bonds

Tenaya Therapeutics Predictive Daily Indicators

Tenaya Therapeutics Corporate Filings

Tenaya Therapeutics Forecast Models

Tenaya Therapeutics' time-series forecasting models are one of many Tenaya Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tenaya Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tenaya Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tenaya shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tenaya Therapeutics. By using and applying Tenaya Stock analysis, traders can create a robust methodology for identifying Tenaya entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tenaya analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tenaya analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tenaya Therapeutics stock analysis indicators help investors evaluate how Tenaya Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tenaya Therapeutics shares will generate the highest return on investment. By understating and applying Tenaya Therapeutics stock analysis, traders can identify Tenaya Therapeutics position entry and exit signals to maximize returns.

When running Tenaya Therapeutics' price analysis, check to measure Tenaya Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenaya Therapeutics is operating at the current time. Most of Tenaya Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenaya Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenaya Therapeutics' price. Additionally, you may evaluate how the addition of Tenaya Therapeutics to your portfolios can decrease your overall portfolio volatility.